By F. Randy Vogenberg, PhD Dr. Vogenberg is Principal, Institute for Integrated Healthcare, and Board Leader, Employer Provider Council, Greenville, SC Employers can wield tremendous leverage in optimizing biosimilar uptake, but they have remained relatively disengaged to date. The successful record of biosimilar competition lowering biologic drug costs can be far better supported by self-insured … Continue reading Employer Plans, Private-Label Biosimilars, Little Transparency